CN104645246A - 一种用于女性更年期抑郁的药物制剂 - Google Patents
一种用于女性更年期抑郁的药物制剂 Download PDFInfo
- Publication number
- CN104645246A CN104645246A CN201510110948.7A CN201510110948A CN104645246A CN 104645246 A CN104645246 A CN 104645246A CN 201510110948 A CN201510110948 A CN 201510110948A CN 104645246 A CN104645246 A CN 104645246A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pharmaceutical preparation
- fructus
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 24
- 206010067371 Menopausal depression Diseases 0.000 title abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 241000218176 Corydalis Species 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 229940052810 complex b Drugs 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 5
- 239000002775 capsule Substances 0.000 abstract description 4
- 239000002552 dosage form Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 4
- 240000007185 Albizia julibrissin Species 0.000 abstract 1
- 235000011468 Albizia julibrissin Nutrition 0.000 abstract 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000131360 Morinda citrifolia Species 0.000 abstract 1
- 235000008898 Morinda citrifolia Nutrition 0.000 abstract 1
- 235000008248 Morinda citrifolia var citrifolia Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 244000081822 Uncaria gambir Species 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 235000017524 noni Nutrition 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 26
- 238000011282 treatment Methods 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 208000024714 major depressive disease Diseases 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 208000020401 Depressive disease Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 201000003995 melancholia Diseases 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 239000000935 antidepressant agent Substances 0.000 description 3
- 229940005513 antidepressants Drugs 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000003001 depressive effect Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000000955 neuroendocrine Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- IGLYMJRIWWIQQE-QUOODJBBSA-N (1S,2R)-2-phenylcyclopropan-1-amine (1R,2S)-2-phenylcyclopropan-1-amine Chemical compound N[C@H]1C[C@@H]1C1=CC=CC=C1.N[C@@H]1C[C@H]1C1=CC=CC=C1 IGLYMJRIWWIQQE-QUOODJBBSA-N 0.000 description 1
- CHZJRGNDJLJLAW-RIQJQHKOSA-N (8r,9s,13s,14s,16r,17r)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-16,17-diol Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1C[C@@H](O)[C@@]4(O)C#C)C)CC2=CC=3OC1CCCC1 CHZJRGNDJLJLAW-RIQJQHKOSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- XKFPYPQQHFEXRZ-UHFFFAOYSA-N 5-methyl-N'-(phenylmethyl)-3-isoxazolecarbohydrazide Chemical compound O1C(C)=CC(C(=O)NNCC=2C=CC=CC=2)=N1 XKFPYPQQHFEXRZ-UHFFFAOYSA-N 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 206010031127 Orthostatic hypotension Diseases 0.000 description 1
- 229940087098 Oxidase inhibitor Drugs 0.000 description 1
- RMUCZJUITONUFY-UHFFFAOYSA-N Phenelzine Chemical compound NNCCC1=CC=CC=C1 RMUCZJUITONUFY-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- XXPVSQRPGBUFKM-SAPNQHFASA-N clovoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(Cl)C=C1 XXPVSQRPGBUFKM-SAPNQHFASA-N 0.000 description 1
- 229950002663 clovoxamine Drugs 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960003914 desipramine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 201000003104 endogenous depression Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- -1 heat Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229950007863 nilestriol Drugs 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960000964 phenelzine Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- 229960002073 sertraline Drugs 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- WBWWGRHZICKQGZ-HZAMXZRMSA-M taurocholate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-M 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960003741 tranylcypromine Drugs 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-O tyraminium Chemical compound [NH3+]CCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-O 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例次 | 痊愈 | 显著进步 | 进步 | 无效 | 总有效率(%) |
治疗组 | 51 | 21 | 15 | 11 | 4 | 92 |
对照组 | 51 | 15 | 12 | 6 | 18 | 65 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510110948.7A CN104645246B (zh) | 2015-03-15 | 2015-03-15 | 一种用于女性更年期抑郁的药物制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510110948.7A CN104645246B (zh) | 2015-03-15 | 2015-03-15 | 一种用于女性更年期抑郁的药物制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104645246A true CN104645246A (zh) | 2015-05-27 |
CN104645246B CN104645246B (zh) | 2017-12-01 |
Family
ID=53237215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510110948.7A Expired - Fee Related CN104645246B (zh) | 2015-03-15 | 2015-03-15 | 一种用于女性更年期抑郁的药物制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104645246B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105688088A (zh) * | 2016-04-03 | 2016-06-22 | 马兆峰 | 一种用于治疗更年期抑郁症综合征的药物制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1850234A (zh) * | 2006-02-24 | 2006-10-25 | 石圣洪 | 妇宁康薄膜衣片及其制备方法 |
CN101530599A (zh) * | 2009-04-20 | 2009-09-16 | 高新华 | 一种治疗精神抑郁的药物组合物 |
KR20140130286A (ko) * | 2013-04-30 | 2014-11-10 | 주식회사 이노한방 | 포공영 추출물을 포함하는 우울증 예방 또는 치료용 조성물 |
-
2015
- 2015-03-15 CN CN201510110948.7A patent/CN104645246B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1850234A (zh) * | 2006-02-24 | 2006-10-25 | 石圣洪 | 妇宁康薄膜衣片及其制备方法 |
CN101530599A (zh) * | 2009-04-20 | 2009-09-16 | 高新华 | 一种治疗精神抑郁的药物组合物 |
KR20140130286A (ko) * | 2013-04-30 | 2014-11-10 | 주식회사 이노한방 | 포공영 추출물을 포함하는 우울증 예방 또는 치료용 조성물 |
Non-Patent Citations (1)
Title |
---|
张广强等: "枣仁补血汤联合氟西汀治疗更年期抑郁症38例临床观察", 《北京中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105688088A (zh) * | 2016-04-03 | 2016-06-22 | 马兆峰 | 一种用于治疗更年期抑郁症综合征的药物制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN104645246B (zh) | 2017-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101711847B (zh) | 一种治疗抑郁症、焦虑症的口服中药制剂 | |
CN104274789A (zh) | 一种治疗抑郁的中药组合物 | |
CN103585479A (zh) | 用于治疗缺铁性贫血的补血丸和补血胶囊 | |
CN103599474B (zh) | 一种用于治疗睡眠质量差的中药组合物 | |
CN102370727A (zh) | 一种治疗抑郁症的中药复方制剂及其制备方法 | |
CN103520665A (zh) | 一种孕妇妊娠初期安胎的中药及其制备方法 | |
CN101194982B (zh) | 一种抗抑郁的中药组合物及其制备方法 | |
CN104623314A (zh) | 用于治疗口干口苦的药物组合物及其制备方法 | |
CN104383420A (zh) | 制备治疗失眠多梦药物制剂的方法 | |
CN104383421A (zh) | 用于失眠多梦的药物制剂 | |
CN104645246B (zh) | 一种用于女性更年期抑郁的药物制剂 | |
CN104888124A (zh) | 盐酸米安色林的合成工艺及其检测方法 | |
CN104645245B (zh) | 一种用于女性更年期抑郁药物制剂的制备方法 | |
CN105012864A (zh) | 盐酸米安色林新晶型及其检测方法和应用 | |
CN104352973A (zh) | 一种用于产后抑郁的中成药 | |
CN101129492A (zh) | 一种治疗抑郁症的中药制剂 | |
CN104352994A (zh) | 用于性功能障碍的药物制剂 | |
CN104491677A (zh) | 一种治疗性功能障碍药物的制备方法 | |
CN104740148B (zh) | 一种治疗脑卒中后抑郁的中药组合物及其制备方法 | |
CN103301414B (zh) | 抗痛风、促肾排、修肾损药物组合物及其制备方法和应用 | |
CN104383440A (zh) | 一种内服治疗抑郁的药物制剂 | |
CN102416147B (zh) | 一种治疗戒毒人员的躁狂症的药物组合物 | |
CN103191293A (zh) | 一种防治亚健康的药物组合物及其制备方法 | |
CN103550711B (zh) | 一种治疗月经病的药物以及制备方法 | |
CN103127358B (zh) | 一种治疗类风湿关节炎的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ni Ruiyun Inventor after: Zhang Dongmei Inventor after: Feng Juan Inventor after: Wang Xiangfeng Inventor before: Chen Mingyou |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171106 Address after: 276199 the first people's Hospital of Tancheng County, 159 North Ring Road, Shandong, Tancheng Applicant after: Ni Ruiyun Applicant after: Zhang Dongmei Address before: 276300 Yinan psychological rehabilitation hospital, Linyi, Shandong Applicant before: Chen Mingyou |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190402 Address after: 226100 No. 101, Nine Groups, Banqiao Village, Zhengyu Town, Haimen City, Nantong City, Jiangsu Province Patentee after: Haimen Chuanghao Industrial Design Co.,Ltd. Address before: 276199 First People's Hospital of Tancheng County, No. 159 North Ring Road, Tancheng County, Shandong Province Co-patentee before: Zhang Dongmei Patentee before: Ni Ruiyun |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171201 |